In Reply
- PMID: 35325206
- PMCID: PMC9074959
- DOI: 10.1093/oncolo/oyac058
In Reply
Abstract
This letter to the editor responds to Morelli et al, continuing the discussion on the implementation of DPYD genotyping.
Comment on
-
Pathogenic DPYD Variants and Treatment-Related Mortality in Patients Receiving Fluoropyrimidine Chemotherapy: A Systematic Review and Meta-Analysis.Oncologist. 2021 Dec;26(12):1008-1016. doi: 10.1002/onco.13967. Epub 2021 Sep 29. Oncologist. 2021. PMID: 34506675 Free PMC article.
-
Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping.Oncologist. 2022 May 6;27(5):e420-e421. doi: 10.1093/oncolo/oyac057. Oncologist. 2022. PMID: 35325223 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
